FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
Pfizer Plans to Increase U.S. Drug Prices in January
Phase 2 Results for Mavrilimumab Are In
Turmeric: The Evidence for Therapeutic Use for Arthritis
Walmart, Home Depot Adopt Health Insurer Tactic in Drug Copay Battle
5-Year Data on Secukinumab in AS; Oliceridine Not Recommended for FDA Approval
FDA Approves Subcutaneous Tocilizumab for Ages 2–17
Trump Seeks to Base Medicare Drug Prices on Lower Overseas Rates
FDA Rejects Novartis Bid to Repurpose Inflammation Drug for Heart Attacks
- 1
- 2
- 3
- …
- 87
- Next Page »